ST. LOUIS, Aug. 16, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (STXS) (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that ...

ST. LOUIS, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (STXS) (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the ...

Stereotaxis announced that it has received European CE Mark approval for its MAGiC™ ablation catheter, marking a significant step in advancing robotic technology in electrophysiology. Designed for ...

ST. LOUIS, Nov. 7, 2011 /PRNewswire/ -- Stereotaxis, Inc. (NASDAQ: STXS) announced today the launch of Odyssey Cinema™ Studio, an industry-first clinical procedure online broadcast platform providing ...

Stereotaxis (AMEX:STXS), a U.S. medical robotics company, announced that the first-ever procedures using its new Genesis Robotic Magnetic Navigation System have been successfully performed. The ...

ST. LOUIS, Sept. 11, 2017 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX:STXS), a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced today that ...

Stereotaxis has received Food and Drug Administration approval for a robotically navigated magnetic ablation catheter, the company said Tuesday. The approval positions users of Stereotaxis’ robotic ...

ST. LOUIS and CARLSBAD, Calif., March 15, 2019 /PRNewswire/ -- Stereotaxis (OTCQX: STXS) and Acutus Medical today announced the first patients have been successfully treated utilizing integrated ...

ST. LOUIS and MARLBOROUGH, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, and ...

The Odyssey Cinema Studio solution is the latest addition to the Company's Odyssey™ family of products, which provides hospitals with the necessary information management platform to manage, control, ...